Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused.

Tris Pharma’s opioid alternative has scored a third win in a trio of clinical trials, providing the biotech with the data needed to take the pain relief drug to the FDA this year. The latest ...

Tris Pharma's recent recall of infant ibuprofen comes less than a year after federal regulators told the drugmaker to clean up its act, citing numerous manufacturing violations. The New Jersey ...